Purpose in Life Survey

Breast Cancer Clinical Trial

— PIL  

Official title:

Evaluating the Prevalence of Purpose-related Existential Distress Among 2 Clinical Populations Compared to a Normative Sample

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT05790278
• Other study ID #: 1920306
• Status: Enrolling by invitation
• Start date: August 1, 2022
• Est. completion date: August 31, 2024

Study information

• Verified date: February 2024
• Source: Allina Health System
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

At present, there is no empirical data that specifies the likely prevalence of purpose in life disruption among various clinical populations. Between one-third and one-half of cancer survivors report some degree of existential distress during or after their treatment, but these findings are not specific to the domain of purpose in life. To address the aforementioned gap, we propose to conduct a survey study to determine the prevalence of purpose disruption in two clinical populations and determine if the prevalence of purpose disruption in these populations is different from that of a normative population.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 300
• Est. completion date: August 31, 2024
• Est. primary completion date: August 31, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age 18+
• Stage 1, 2, 3 cancer
• Cancer types: breast cancer, non-Hodgkin's lymphoma; colorectal cancer
• Receiving oncology services or treatment through AHCI
• Have completed primary cancer treatment within the past 12 months
• Able to communicate in English;
• Able to see and read (with or without assistive devices);
• Has access to a device (computer, phone, tablet) and an email address;
• Access to an internet connection.
• Has a known email address (in EPIC) and/or home telephone number
• Adults who sustained a traumatic brain injury within the past 12 months.
• Attending the 2022 MN State Fair

Exclusion Criteria:

• Have declined consent for use of medical records in research during admission to AH facility

Related Conditions & MeSH terms

• Brain Injuries
• Brain Injuries, Traumatic
• Breast Cancer
• Traumatic Brain Injury

Intervention

Other:
• Survey
Completion of a Purpose in Life Survey

Locations

Country	Name	City	State
United States	Abbott Northwestern Hospital	Minneapolis	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
Mary Radomski

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Purpose Status Question	A single forced-choice self-report screener question that we developed in order to characterize existential distress related to purpose in life (PSQ: "Related to living with purpose in life, right now I am: moving backwards; stalled; figuring it out; moving forward on a path").	Through Study Completion, about 15 minutes
Secondary	Work and Adjustment Scale	A 5-item self-report questionnaire to characterize functioning related to work, social life, leisure, home management, and relationships.	Through Study Completion, about 15 minutes
Secondary	Meaning in Life Questionnaire	A 10-item questionnaire designed to measure 2 dimensions of meaning in life: Presence of Meaning (how much respondents feel their lives have meaning) and Search for Meaning (how much respondents strive to find meaning and understanding in their lives).	Through Study Completion, about 15 minutes
Secondary	Life Engagement Test	A 6-item self-report questionnaire that captures the extent to which a person engages in activities that are personally valued.	Through Study Completion, about 15 minutes